(Q37821012)

English

Criteria of evidence to move potential chemopreventive agents into late phase clinical trials.

scientific article published on December 2011

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

21158704

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21158704%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

review article

1 reference

stated in

Europe PubMed Central

title

Criteria of evidence to move potential chemopreventive agents into late phase clinical trials (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

21158704

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21158704%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

3

1 reference

stated in

Europe PubMed Central

PubMed ID

21158704

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21158704%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

author name string

Ronan J Kelly

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed ID

21158704

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21158704%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

Ariel Lopez-Chavez

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

21158704

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21158704%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

publication date

1 December 2011

1 reference

stated in

Europe PubMed Central

PubMed ID

21158704

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21158704%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

Europe PubMed Central

PubMed ID

21158704

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21158704%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

volume

12

1 reference

stated in

Europe PubMed Central

PubMed ID

21158704

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21158704%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

issue

13

1 reference

stated in

Europe PubMed Central

PubMed ID

21158704

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21158704%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

page(s)

1983-1988

1 reference

stated in

Europe PubMed Central

PubMed ID

21158704

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21158704%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

Identifiers

DOI

10.2174/138945011798184173

1 reference

stated in

Europe PubMed Central

PubMed ID

21158704

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21158704%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

Europe PubMed Central

PubMed ID

21158704

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21158704%20AND%20SRC:MED&resulttype=core&format=json

(Q37821012)

Criteria of evidence to move potential chemopreventive agents into late phase clinical trials.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)